| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 76.70B | 78.65B | 76.01B | 72.74B | 68.80B | 62.47B |
| Gross Profit | 16.60B | 17.55B | 16.57B | 14.04B | 12.14B | 11.63B |
| EBITDA | 7.85B | 7.80B | 7.49B | 5.64B | 3.39B | 4.34B |
| Net Income | 5.27B | 4.26B | 5.10B | 2.81B | 1.29B | 896.00M |
Balance Sheet | ||||||
| Total Assets | 118.34B | 125.42B | 122.86B | 126.19B | 116.29B | 113.93B |
| Cash, Cash Equivalents and Short-Term Investments | 32.24B | 38.52B | 35.86B | 33.32B | 30.51B | 35.03B |
| Total Debt | 4.04B | 4.25B | 3.12B | 2.97B | 2.08B | 2.59B |
| Total Liabilities | 38.53B | 38.76B | 39.22B | 43.87B | 38.24B | 35.27B |
| Stockholders Equity | 79.81B | 86.57B | 83.64B | 82.32B | 78.04B | 77.99B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.56B | 5.66B | 1.95B | -3.04B | 4.22B |
| Operating Cash Flow | 0.00 | 8.20B | 6.51B | 3.17B | -1.13B | 5.91B |
| Investing Cash Flow | 0.00 | -1.88B | -1.83B | -1.99B | -1.88B | -2.83B |
| Financing Cash Flow | 0.00 | -4.41B | -3.76B | -1.13B | -2.17B | -1.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥320.27B | 14.75 | 7.67% | 0.91% | 11.51% | 46.17% | |
74 Outperform | ¥96.85B | 17.51 | 7.00% | 3.02% | 8.49% | -0.33% | |
73 Outperform | ¥56.30B | 14.37 | ― | 2.54% | 3.47% | -12.26% | |
71 Outperform | ¥91.75B | 14.50 | 9.39% | 1.68% | 7.26% | 28.36% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥36.42B | 29.20 | ― | 3.56% | -2.79% | -35.37% | |
52 Neutral | ¥87.03B | 27.20 | 5.02% | 3.23% | -21.03% | -91.77% |